• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2010年肝癌AHPBA/SSO/SSAT共识会议总结

Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC.

作者信息

Munene Gitonga, Vauthey Jean-Nicolas, Dixon Elijah

机构信息

Division of General Surgery, University of Calgary, AB, Canada T2N 1N4.

出版信息

Int J Hepatol. 2011;2011:565060. doi: 10.4061/2011/565060. Epub 2011 May 17.

DOI:10.4061/2011/565060
PMID:21994863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3170834/
Abstract

Under the auspices of the American Hepato-Pancreato-Biliary Association, an expert consensus conference was convened in January 2010 on the multidisciplinary management of hepatocellular carcinoma. The goals of the conference were to address knowledge gaps in the optimal preparation of patients with HCC for operative therapy, best methods to control HCC while awaiting liver transplantation, and developing a multidisciplinary approach to these patients with implementation of novel systemic therapies.

摘要

在美国肝胰胆协会的支持下，2010年1月召开了一次关于肝细胞癌多学科管理的专家共识会议。该会议的目标是解决肝细胞癌患者手术治疗最佳准备方面的知识空白、等待肝移植期间控制肝细胞癌的最佳方法，以及通过实施新型全身治疗为这些患者制定多学科治疗方法。

相似文献

1
Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC.2010年肝癌AHPBA/SSO/SSAT共识会议总结
Int J Hepatol. 2011;2011:565060. doi: 10.4061/2011/565060. Epub 2011 May 17.
2
AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.美国肝脏胰胆协会/外科肿瘤学会/肉瘤及软组织肿瘤学会主办的肝细胞癌多学科治疗共识会议。
HPB (Oxford). 2010 Jun;12(5):287-8. doi: 10.1111/j.1477-2574.2010.00184.x.
3
Management of early hepatocellular carcinoma: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.早期肝细胞癌的管理：美洲肝胆胰协会德尔菲共识过程的结果。
HPB (Oxford). 2021 May;23(5):753-761. doi: 10.1016/j.hpb.2020.09.013. Epub 2020 Sep 30.
4
AHPBA/SSO/SSAT Consensus Conference on hepatic colorectal metastases: rationale and overview of the conference. January 25, 2006.肝结直肠癌转移的AHPBA/SSO/SSAT共识会议：会议的基本原理与概述。2006年1月25日。
Ann Surg Oncol. 2006 Oct;13(10):1259-60. doi: 10.1245/s10434-006-9017-9. Epub 2006 Sep 2.
5
Intrahepatic cholangiocarcinoma: expert consensus statement.肝内胆管癌：专家共识声明
HPB (Oxford). 2015 Aug;17(8):669-80. doi: 10.1111/hpb.12441.
6
AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases.美国病理学家协会/外科肿瘤学会/肉瘤肿瘤学会主办的关于结直肠癌转移多学科治疗的共识会议。
HPB (Oxford). 2013 Feb;15(2):89-90. doi: 10.1111/j.1477-2574.2012.00569.x.
7
Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements.北美肝胆胰外科培训共识会议：会议综述及共识声明介绍
Ann Surg Oncol. 2016 Jul;23(7):2153-60. doi: 10.1245/s10434-016-5111-9. Epub 2016 Mar 1.
8
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference.关于可切除及临界可切除胰腺癌的AHPBA/SSO/SSAT共识会议：会议的基本原理及概述
Ann Surg Oncol. 2009 Jul;16(7):1725-6. doi: 10.1245/s10434-009-0409-5. Epub 2009 Apr 24.
9
Advances in hepato-pancreato biliary surgery.肝胆胰外科学进展。
Expert Rev Gastroenterol Hepatol. 2011 Aug;5(4):457-60. doi: 10.1586/egh.11.39.
10
Hilar cholangiocarcinoma: expert consensus statement.肝门部胆管癌：专家共识声明
HPB (Oxford). 2015 Aug;17(8):691-9. doi: 10.1111/hpb.12450.

引用本文的文献

1
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis.利用影像基因组分析破译伴有微血管侵犯的肝细胞癌的肿瘤内异质性。
J Transl Med. 2023 Oct 18;21(1):734. doi: 10.1186/s12967-023-04586-6.
2
Management and survival for patients with stage-I hepatocellular carcinoma: An observational study based on SEER database.I期肝细胞癌患者的管理与生存：一项基于监测、流行病学和最终结果（SEER）数据库的观察性研究。
Medicine (Baltimore). 2020 Oct 9;99(41):e22118. doi: 10.1097/MD.0000000000022118.
3
Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database.一线射频消融与手术治疗早期肝细胞癌患者生存差异的研究：基于监测、流行病学和最终结果数据库的一项人群研究。
Med Sci Monit. 2020 May 28;26:e921782. doi: 10.12659/MSM.921782.
4
Comparative Effectiveness of Radiofrequency Ablation, Surgical Resection and Transplantation for Early Hepatocellular Carcinoma by Cancer Risk Groups: Results of Propensity Score-Weighted Analysis.按癌症风险分组比较射频消融、手术切除和肝移植治疗早期肝细胞癌的疗效：倾向评分加权分析结果
Onco Targets Ther. 2019 Nov 29;12:10389-10400. doi: 10.2147/OTT.S224809. eCollection 2019.
5
Staging systems of hepatocellular carcinoma: A review.肝细胞癌的分期系统：综述
Indian J Gastroenterol. 2018 Nov;37(6):481-491. doi: 10.1007/s12664-018-0915-0. Epub 2018 Dec 29.
6
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.中间型肝细胞癌的肝移植：一种适应性方法。
World J Gastroenterol. 2017 May 14;23(18):3195-3204. doi: 10.3748/wjg.v23.i18.3195.
7
Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma.原发性肝细胞癌肝叶切除术后四年出现孤立淋巴结转移复发。
World J Hepatol. 2016 Aug 18;8(23):994-8. doi: 10.4254/wjh.v8.i23.994.
8
Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.白蛋白与碱性磷酸酶比值：一种用于肝细胞癌的新型预后指标。
Dis Markers. 2015;2015:564057. doi: 10.1155/2015/564057. Epub 2015 Feb 9.

本文引用的文献

1
Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.钆塞酸二钠增强与弥散加权磁共振成像在肝纤维化分期中的比较：初步观察。
Radiology. 2011 Apr;259(1):142-50. doi: 10.1148/radiol.10100621. Epub 2011 Jan 19.
2
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.肝癌联合治疗的非手术治疗方法：专家共识声明。
HPB (Oxford). 2010 Jun;12(5):313-20. doi: 10.1111/j.1477-2574.2010.00183.x.
3
Surgical treatment of hepatocellular carcinoma: expert consensus statement.肝细胞癌的外科治疗：专家共识声明。
HPB (Oxford). 2010 Jun;12(5):302-10. doi: 10.1111/j.1477-2574.2010.00182.x.
4
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.肝细胞癌的预处理评估：专家共识声明。
HPB (Oxford). 2010 Jun;12(5):289-99. doi: 10.1111/j.1477-2574.2010.00181.x.
5
AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.美国肝脏胰胆协会/外科肿瘤学会/肉瘤及软组织肿瘤学会主办的肝细胞癌多学科治疗共识会议。
HPB (Oxford). 2010 Jun;12(5):287-8. doi: 10.1111/j.1477-2574.2010.00184.x.
6
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.检测和描述肝脏局灶性病变：一项日本 III 期、多中心的钆塞酸二钠增强磁共振成像与增强计算机断层扫描对比研究，主要针对肝细胞癌和慢性肝病患者。
Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.
7
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.钇[90Y]微球放射性栓塞治疗肝细胞癌：长期疗效的综合报告。
Gastroenterology. 2010 Jan;138(1):52-64. doi: 10.1053/j.gastro.2009.09.006. Epub 2009 Sep 18.
8
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.301 例连续扩大右半肝切除术：基于系统肝体积测量的结果评估。
Ann Surg. 2009 Oct;250(4):540-8. doi: 10.1097/SLA.0b013e3181b674df.
9
Laparoscopic liver resection: a systematic review.腹腔镜肝切除术：一项系统评价。
J Hepatobiliary Pancreat Surg. 2009;16(4):410-21. doi: 10.1007/s00534-009-0120-8. Epub 2009 Jun 4.
10
Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?肝细胞癌患者根据门静脉肿瘤切除术方法的生存率是否存在差异？
Surgery. 2009 Jan;145(1):9-19. doi: 10.1016/j.surg.2008.09.005.